Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC

•Download as PPT, PDF•

0 likes•210 views

PVI, PeerView Institute for Medical Education

Chair & Presenter, Melissa L. Johnson, MD, Benjamin Levy, MD, and Helena A. Yu, MD, discuss treatment advances with HER2-, HER3-, and TROP2-targeted agents for lung cancer in this CME/MOC activity titled “Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC.” For the full presentation, downloadable Practice Aids, slides and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3hnN6Ly. CME/MOC credit will be available until October 14, 2022.

Health & Medicine

Harnessing the Potential of HER2-, HER3-, and TROP2-Targeted Therapies to Address Unmet Needs in Advanced NSCLC

What's hot

Rectal cancer Preoperative Radiotherapy- Short vs long course

Gaurav Kumar

MANAGEMENT OF LUMINAL BREAST CANCER.pptx

Cancer surgery By Royapettah Oncology Group

Chair, Marina Chiara Garassino, MD, Hossein Borghaei, DO, MS, and Stephen V. Liu, MD, discuss NSCLC in this CME/MOC activity titled “Are You Prepared for the New Wave of ADCs in NSCLC? Innovative Approaches and Practical Considerations in Targeting HER2, HER3, TROP2, and Other Alterations in Advanced Lung Cancer.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3wY601T. CME/MOC credit will be available until October 24, 2023.

Are You Prepared for the New Wave of ADCs in NSCLC? Innovative Approaches and...

PVI, PeerView Institute for Medical Education

What are the latest treatment advances for HER2-positive metastatic breast cancer? Eric Winer, MD, director of the Breast Cancer Program in the Susan F. Smith Center for Women's Cancers, discusses some of the latest research and treatment options. This presentation was originally given as part of the 2015 Metastatic Breast Cancer Forum, held on October 17 at Dana-Farber Cancer Institute in Boston, Mass. For more information, visit www.susanfsmith.org

The Latest Treatments for HER2-Positive Breast Cancer

Dana-Farber Cancer Institute

Target Audience This activity has been designed to meet the educational needs of medical oncologists, radiation oncologists, surgical oncologists, APNs, RNs, pharmacists, managed care pharmacy directors, pathologists, medical directors, allied health professionals, and other physicians affiliated with medical facilities treating patients with head and neck cancers (HNC). HNC are challenging to treat due to the complex and aggressive nature of these cancers. Timely diagnosis and referral to the appropriate specialist is imperative as early diagnosis can lead to reduced mortality. Clinical advances are evolving regarding the use of molecularly targeted therapies such as EGFR inhibitors and anti-angiogenic agents into the multidisciplinary treatment of HNC. Optimal disease management, rehabilitation, and survivorship care depend on access to a multidisciplinary team comprised of a spectrum of specialists and support services. As research advances, clinicians need to remain aware of this new evidence to understand the multidisciplinary clinical practice implications that can affect patient care. This series of live grand rounds, webinars, and enduring curriculum include a didactic presentation, case illustrations, and clinical resources and tools.

A Multidisciplinary Approach to Personalizing the Treatment of Head & Neck Ca...

Institute For Medical Education and Research (IMER)

Prostate carcinoma- hormonal therapy 1

GovtRoyapettahHospit

Radiation for Colon and Rectal Cancer

Robert J Miller MD

Tumor conferences are multidisciplinary meetings at which the management of cancer patients is discussed. They have been an integral part of oncology services and are regarded as an essential component of quality control and continuing medical education. There are data to suggest that the tumor conference enhances patient care. Many studies of effectiveness have been conducted. Reported beneﬁts include improved patient management and treatment. In this presentation, I'll try to assess the role of the multidisciplinary tumor conference in patient management in gynecologic oncology services.

Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...

Emad Shash

Cervix landmark trials- kiran

Kiran Ramakrishna

Prophylactic cranial irradiation

Shreya Singh

INDUCTION CHEMOTHERAPY WITH TPF IN HEAD & NECK CANCERS

Paul George

FITTER TRADE TEST

Nyiko smart Mpenyane

Degree Certificate

Gayathri AnilKumar

Witch Hunt là một trò chơi biện luận, ẩn vai trò. Bạn sẽ vào vai những cư dân trong một ngôi làng, nơi mà bọn phù thùy đã thâm nhập vào để thực hiện mưu đồ của chúng. Ván chơi được chia làm 2 giai đoạn chính luân phiên. Vào ban đêm, phù thủy sẽ bàn bạc với nhau để thủ tiêu 1 người. Đến ban ngày, những người dân trong làng sẽ cùng bàn luận để treo cổ 1 người (với hy vọng đó là phù thủy). Tất nhiên, bọn phù thủy ranh ma đã tìm cách trà trộn vào dân làng. Vì vậy, mấu chốt của trò chơi nằm ở việc bạn tin tưởng ai. Witch Hunt khắc phục được nhiều nhược điểm của dòng game biện luận - ẩn vai trò: - Các nhân vật đã chết vẫn có thể tiếp tục tham gia vào ván chơi - Mỗi người chơi (bất kể là phe nào) đều có những năng lực đặc biệt riêng. Điều này đem lại chiều sâu chiến thuật và nâng cao độ chơi lại cho trò chơi.

Hướng dẫn luật chơi Witch Hunt

Board Game Việt

Management of carcinomas of urinary bladder

Shashank Bansal

Chapter 25 assessment of clincal responses

Nilesh Kucha

Management carcinoma oropharynx

Sagar Raut

Neoadjuvant or adjuvant immunotherapy in melanoma stage iii

Sameer Rastogi

Chair, Brendon M. Stiles, MD, Boris Sepesi, MD, and Catherine Shu, MD, discuss immunotherapy advances in lung cancer in this CME/MOC/CC activity titled “Immunotherapy as a Game-Changer in Multimodal Management of Locally Advanced and Earlier Stages of Lung Cancer.” For the full presentation, downloadable Practice Aids, monograph, and complete CME/MOC/CC information, and to apply for credit, please visit us at https://bit.ly/3qfOXmB. CME/MOC/CC credit will be available until May 20, 2022.

Immunotherapy as a Game-Changer in Multimodal Management of Locally Advanced ...

PVI, PeerView Institute for Medical Education

Contouring guidelines of carcinoma cervix

umesh V

What's hot (20)

Rectal cancer Preoperative Radiotherapy- Short vs long course

MANAGEMENT OF LUMINAL BREAST CANCER.pptx

Are You Prepared for the New Wave of ADCs in NSCLC? Innovative Approaches and...

The Latest Treatments for HER2-Positive Breast Cancer

A Multidisciplinary Approach to Personalizing the Treatment of Head & Neck Ca...

Prostate carcinoma- hormonal therapy 1

Radiation for Colon and Rectal Cancer

Impact of Multidisciplinary Discussion on Treatment Outcome For Gynecologic C...

Cervix landmark trials- kiran

Prophylactic cranial irradiation

INDUCTION CHEMOTHERAPY WITH TPF IN HEAD & NECK CANCERS

FITTER TRADE TEST

Degree Certificate

Hướng dẫn luật chơi Witch Hunt

Management of carcinomas of urinary bladder

Chapter 25 assessment of clincal responses

Management carcinoma oropharynx

Neoadjuvant or adjuvant immunotherapy in melanoma stage iii

Immunotherapy as a Game-Changer in Multimodal Management of Locally Advanced ...

Contouring guidelines of carcinoma cervix

More from PVI, PeerView Institute for Medical Education

Co-Chairs and Presenter Marianne Davies, DNP, ACNP, AOCNP, FAAN, Beth Sandy, MSN, CRNP, FAPO, and Matthew A. Gubens, MD, MS, FASCO, prepared useful Practice Aids pertaining to NSCLC for this CME/MOC/NCPD/ILNA/IPCE activity titled “Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/ILNA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3RDokbZ. CME/MOC/NCPD/ILNA/IPCE credit will be available until May 24, 2025.

Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...

PVI, PeerView Institute for Medical Education

Co-Chairs and Presenter Marianne Davies, DNP, ACNP, AOCNP, FAAN, Beth Sandy, MSN, CRNP, FAPO, and Matthew A. Gubens, MD, MS, FASCO, discuss NSCLC in this CME/MOC/NCPD/ILNA/IPCE activity titled “Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices for Patient Education, irAE Management, and Survivorship Care.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/ILNA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3RDokbZ. CME/MOC/NCPD/ILNA/IPCE credit will be available until May 24, 2025.

Making Patient-Centric Immunotherapy a Reality in Lung Cancer: Best Practices...

PVI, PeerView Institute for Medical Education

Co-Chairs, Sia Daneshmand, MD, and Matthew D. Galsky, MD, discuss bladder cancer in this CME/MOC/NCPD/AAPA/IPCE activity titled “Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Strategies for Integrating the Latest Evidence and Treatment Advances.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3OOeYbO. CME/MOC/NCPD/AAPA/IPCE credit will be available until May 13, 2025.

Modern Team-Based Therapeutic Management for Bladder Cancer Care: Expert Stra...

PVI, PeerView Institute for Medical Education

Chair Jamie Carroll, APRN, CNP, MSN, discusses breast cancer in this NCPD/ILNA/AAPA activity titled “Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy in TNBC and HR+, HER2- Breast Cancer: Best Practices for Adverse Event Management and Patient Education.” For the full presentation, downloadable Practice Aids, and complete NCPD/ILNA/AAPA information, and to apply for credit, please visit us at https://bit.ly/3SdnvWt. NCPD/ILNA/AAPA credit will be available until May 8, 2025.

Nurses at the Forefront of Maximizing the Potential of TROP2-Targeted Therapy...

PVI, PeerView Institute for Medical Education

BTK Inhibition Transforming the Landscape of Chronic Spontaneous Urticaria Tr...

PVI, PeerView Institute for Medical Education

Co-Chairs Milind Desai, MD, MBA, FACC, FAHA, FESC, and Andrew Willeford, PharmD, PhD, BCCP, prepared useful Practice Aids pertaining to hypertrophic cardiomyopathy for this CME/MOC/CPE/AAPA/IPCE activity titled “Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertrophic Cardiomyopathy.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/CPE/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4bb7eKc. CME/MOC/CPE/AAPA/IPCE credit will be available until May 16, 2025.

Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...

PVI, PeerView Institute for Medical Education

Co-Chairs Milind Desai, MD, MBA, FACC, FAHA, FESC, and Andrew Willeford, PharmD, PhD, BCCP, discuss hypertrophic cardiomyopathy in this CME/MOC/CPE/AAPA/IPCE activity titled “Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertrophic Cardiomyopathy.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/CPE/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4bb7eKc. CME/MOC/CPE/AAPA/IPCE credit will be available until May 16, 2025.

Adapting Managed Care Strategies in the Era of Precision Medicine for Hypertr...

PVI, PeerView Institute for Medical Education

Exploring the Evidence: Improving Cardiovascular Outcomes and the Role of Wei...

PVI, PeerView Institute for Medical Education

Co-Chairs and Planners Saakshi Khattri, MBBS, MD, FAAD, FACR, Marla Dubinsky, MD, Emma Guttman-Yassky, MD, PhD, and Alexis Ogdie, MD, MSCE, discuss immune-mediated inflammatory diseases in this CME/AAPA activity titled “Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Diseases: Addressing Shared Pathophysiology With JAK Inhibitors.” For the full presentation, downloadable Practice Aids, and complete CME/AAPA information, and to apply for credit, please visit us at https://bit.ly/3JhsIZ7. CME/AAPA credit will be available until April 24, 2025.

Interdisciplinary Approaches to Management of Immune-Mediated Inflammatory Di...

PVI, PeerView Institute for Medical Education

Co-Chairs Alicia K. Morgans, MD, MPH, and Neal D. Shore, MD, FACS, discuss prostate cancer in this CME/MOC/NCPD/CPE/AAPA/IPCE activity titled “Treatment Advances and Individualized Therapeutic Strategies in Prostate Cancer: Expert Insights on Key Evidence, Practical Tips for Personalized Therapy, and Clinical Integration Approaches.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/CPE/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3SQrJ6G. CME/MOC/NCPD/CPE/AAPA/IPCE credit will be available until April 24, 2025.

Treatment Advances and Individualized Therapeutic Strategies in Prostate Canc...

PVI, PeerView Institute for Medical Education

Co-Chairs Prof. Nicolas Girard, MD, PhD, and Aaron Lisberg, MD, discuss NSCLC in this CME/MOC/NCPD/AAPA/IPCE activity titled “Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Cancer: Unveiling Potential, Shaping Tomorrow.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3RmX3dU. CME/MOC/NCPD/AAPA/IPCE credit will be available until April 24, 2025.

Charting a New Path to Better Outcomes With TROP2-Targeting ADCs in Lung Canc...

PVI, PeerView Institute for Medical Education

Co-Chairs, Joseph K. Han, MD, and Seth J. Isaacs, MD, prepared useful Practice Aids pertaining to chronic rhinosinusitis with nasal polyps for this CME/MOC/CC/AAPA/IPCE activity titled “Biologics in CRSwNP: Putting a Paradigm Shift Into Practice.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3Tq6n1G. CME/MOC/CC/AAPA/IPCE credit will be available until May 6, 2025.

Biologics in CRSwNP: Putting a Paradigm Shift Into Practice

PVI, PeerView Institute for Medical Education

Co-Chairs, Joseph K. Han, MD, and Seth J. Isaacs, MD, discuss chronic rhinosinusitis with nasal polyps in this CME/MOC/CC/AAPA/IPCE activity titled “Biologics in CRSwNP: Putting a Paradigm Shift Into Practice.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/CC/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3Tq6n1G. CME/MOC/CC/AAPA/IPCE credit will be available until May 6, 2025.

Biologics in CRSwNP: Putting a Paradigm Shift Into Practice

PVI, PeerView Institute for Medical Education

Co-Chairs, R. Donald Harvey, PharmD, BCOP, FCCP, FHOPA, FASCO, Zahra Mahmoudjafari, PharmD, MBA, BCOP, FHOPA, and James Davis, PharmD, BCOP, discuss multiple myeloma in this CME/CPE/IPCE activity titled “Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering Effective Therapy With Antibody Platforms.” For the full presentation, downloadable Practice Aids, and complete CME/CPE/IPCE information, and to apply for credit, please visit us at https://bit.ly/4aa0iMX. CME/CPE/IPCE credit will be available until May 2, 2025.

Prescriptions for Successful Myeloma Care: Pharmacy Strategies for Delivering...

PVI, PeerView Institute for Medical Education

Co-Chairs, Carlos G. Romo, MD, and Aimee Sato, MD, discuss Neurofibromatosis in this CME/MOC activity titled “Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & Multimodal Care for NF1 pNF and Other Tumors.” For the full presentation, downloadable Practice Aids, and complete CME/MOC information, and to apply for credit, please visit us at https://bit.ly/3SZRz8p. CME/MOC credit will be available until May 2, 2025.

Precision & Progress Against NF1: Solutions for Better Outcomes With MEKi & M...

PVI, PeerView Institute for Medical Education

Chair and Presenters Kathleen N. Moore, MD, MS, Floor J. Backes, MD, and Bhavana Pothuri, MD, MS, prepared useful Practice Aids pertaining to endometrial cancer for this CME/MOC/NCPD/AAPA/IPCE activity titled “Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3SjJyuH. CME/MOC/NCPD/AAPA/IPCE credit will be available until April 17, 2025.

Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...

PVI, PeerView Institute for Medical Education

Chair and Presenters Kathleen N. Moore, MD, MS, Floor J. Backes, MD, and Bhavana Pothuri, MD, MS, discuss endometrial cancer in this CME/MOC/NCPD/AAPA/IPCE activity titled “Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Potential of Immunotherapy, ADCs, PARP Inhibitors, and Other Emerging Treatment Strategies.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/3SjJyuH. CME/MOC/NCPD/AAPA/IPCE credit will be available until April 17, 2025.

Redefining Endometrial and Ovarian Carcinoma Care: Maximizing the Clinical Po...

PVI, PeerView Institute for Medical Education

Chair and Presenters Bradley J. Monk, MD, FACS, FACOG, Kathleen N. Moore, MD, MS, and Ana Oaknin, MD, PhD, discuss gynecologic cancers in this CME/MOC/NCPD/AAPA/IPCE activity titled “Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Implementation Strategies, and Patient Care.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/NCPD/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/4a56tly. CME/MOC/NCPD/AAPA/IPCE credit will be available until April 16, 2025.

Advancing ADCs in Gynecologic Cancers: Expert Insights on Recent Evidence, Im...

PVI, PeerView Institute for Medical Education

Chair Lecia V. Sequist, MD, MPH, and Patrick Nana-Sinkam, MD, FCCP, prepared useful Practice Aids pertaining to lung cancer for this CME/MOC/AAPA/IPCE activity titled “Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/46VvwoP. CME/MOC/AAPA/IPCE credit will be available until April 16, 2025.

Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...

PVI, PeerView Institute for Medical Education

Chair Lecia V. Sequist, MD, MPH, and Patrick Nana-Sinkam, MD, FCCP, discuss lung cancer screening in this CME/MOC/AAPA/IPCE activity titled “Screening and Early Intervention as the Keys to Success in Lung Cancer: A Practical Approach to Implementing Lung Cancer Screening for High-Risk Individuals.” For the full presentation, downloadable Practice Aids, and complete CME/MOC/AAPA/IPCE information, and to apply for credit, please visit us at https://bit.ly/46VvwoP. CME/MOC/AAPA/IPCE credit will be available until April 16, 2025.

Screening and Early Intervention as the Keys to Success in Lung Cancer: A Pra...

PVI, PeerView Institute for Medical Education

More from PVI, PeerView Institute for Medical Education (20)